Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

DRUG(1)
1 unique interventions1 categories

Analytics

Trial Phases

Phase 11

Trial Status

Recruiting1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT04234048Phase 1Recruiting
Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma
Angioimmunoblastic T-cell LymphomaCutaneous T-cell LymphomaCutaneous T-Cell Lymphoma, Unspecified+8 more
PrincipalinvestigatorStart date: 2023-12-18

Research Network

Collaboration Network

10 collaborators·45 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Ann F Mohrbacher, MD

University of Southern California

Very Similar
1 trials

Shared therapeutic areas:

Angioimmunoblastic T-cell LymphomaLymphoma, T-Cell, CutaneousCutaneous T-Cell Lymphoma, Unspecified+8 more

Worked with same sponsors:

SciTech Development, Inc.
Collaborated on 1 trial
Similarity Score114%

Ali Moiin, MD

SciTech Development, Inc.

Very Similar
2 trials

Shared therapeutic areas:

Angioimmunoblastic T-cell LymphomaLymphoma, T-Cell, CutaneousCutaneous T-Cell Lymphoma, Unspecified+8 more

Worked with same sponsors:

SciTech Development, Inc.
Collaborated on 1 trial
Similarity Score114%

Auris O Huen, MD, PharmD

M.D. Anderson Cancer Center

Very Similar
1 trials

Shared therapeutic areas:

Angioimmunoblastic T-cell LymphomaLymphoma, T-Cell, CutaneousCutaneous T-Cell Lymphoma, Unspecified+8 more

Worked with same sponsors:

SciTech Development, Inc.
Collaborated on 1 trial
Similarity Score114%

Barbara Pro, MD

Columbia University

Very Similar
1 trials

Shared therapeutic areas:

Angioimmunoblastic T-cell LymphomaLymphoma, T-Cell, CutaneousCutaneous T-Cell Lymphoma, Unspecified+8 more

Worked with same sponsors:

SciTech Development, Inc.
Collaborated on 1 trial
Similarity Score114%

Jonathan Moreira, M.D.

Northwestern University, Robert H. Lurie Comprehensive Cancer Center

Very Similar
1 trials

Shared therapeutic areas:

Angioimmunoblastic T-cell LymphomaLymphoma, T-Cell, CutaneousCutaneous T-Cell Lymphoma, Unspecified+8 more

Worked with same sponsors:

SciTech Development, Inc.
Collaborated on 1 trial
Similarity Score114%

Brad Haverkos, M.D.

University of Colorado, Denver

Very Similar
1 trials

Shared therapeutic areas:

Angioimmunoblastic T-cell LymphomaLymphoma, T-Cell, CutaneousCutaneous T-Cell Lymphoma, Unspecified+8 more

Worked with same sponsors:

SciTech Development, Inc.
Collaborated on 1 trial
Similarity Score114%

Christiane Querfeld, M.D., Ph.D.

City of Hope Medical Foundation

Very Similar
1 trials

Shared therapeutic areas:

Angioimmunoblastic T-cell LymphomaLymphoma, T-Cell, CutaneousCutaneous T-Cell Lymphoma, Unspecified+8 more

Worked with same sponsors:

SciTech Development, Inc.
Collaborated on 1 trial
Similarity Score114%

Ryan A Wilcox, MD, PhD

University of Michigan

Very Similar
1 trials

Shared therapeutic areas:

Angioimmunoblastic T-cell LymphomaLymphoma, T-Cell, CutaneousCutaneous T-Cell Lymphoma, Unspecified+8 more

Worked with same sponsors:

SciTech Development, Inc.
Collaborated on 1 trial
Similarity Score114%

Dipenkumar Modi, MD

Barbara Ann Karmanos Cancer Institute

Very Similar
1 trials

Shared therapeutic areas:

Angioimmunoblastic T-cell LymphomaLymphoma, T-Cell, CutaneousCutaneous T-Cell Lymphoma, Unspecified+8 more

Worked with same sponsors:

SciTech Development, Inc.
Collaborated on 1 trial
Similarity Score114%

Brenda Sandmaier

Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium

Related
12 trials

Shared therapeutic areas:

Angioimmunoblastic T-cell LymphomaLymphoma, T-Cell, Peripheral
Similarity Score5%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT04234048Phase 1PrincipalInvestigator

Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma

Angioimmunoblastic T-cell LymphomaCutaneous T-cell LymphomaCutaneous T-Cell Lymphoma, Unspecified+8 more
Recruiting

All 1 trials loaded